Zobrazeno 1 - 10
of 42
pro vyhledávání: '"George N, Lambrou"'
Autor:
Igor Kozak, Ian Pearce, Chui Ming Gemmy Cheung, Tobias Machewitz, George N. Lambrou, Daniel Molina, Lima Suleiman, Hossam Youssef, Neil M. Bressler
Publikováno v:
Eye.
Objective To assess ‘time in range’ as a novel measure of treatment response in diabetic macular oedema (DMO). Methods This post hoc analysis of the Protocol T randomised clinical trial included 660 individuals with centre-involved DMO and best-c
Autor:
Thomas Schmelter, Edoardo Midena, Paul Mitchell, Helmut Allmeier, Frank G. Holz, Philip G Hykin, Aries study investigators, Sebastian Wolf, George N. Lambrou, Eric H Souied
Publikováno v:
Retina. 41:1911-1920
Treating neovascular age-related macular degeneration with intravitreal aflibercept treat-and-extend (TE) can reduce treatment burden. ARIES assessed whether intravitreal aflibercept early-start TE was noninferior to late-start TE.A randomized, open-
Autor:
Miltiadis K. Tsilimbaris, Maria I. López-Gálvez, Roberto Gallego-Pinazo, Philippe Margaron, George N. Lambrou
Publikováno v:
Journal of Ophthalmology, Vol 2016 (2016)
Purpose. To review the current literature investigating patient response to antivascular endothelial growth factor-A (VEGF) therapy in the treatment of neovascular age-related macular degeneration (nAMD) and to identify baseline characteristics that
Externí odkaz:
https://doaj.org/article/0c2fa293fbe3434fa834ec45d25d16e1
Autor:
Ian Pearce, Monica Lövestam-Adrian, Rafael Navarro, Paolo Lanzetta, Francisco Rodríguez, David T. Wong, Anat Loewenstein, Annabelle A. Okada, Jean-François Korobelnik, Bora Eldem, Adrian Koh, Antonia M. Joussen, George N. Lambrou, Lihteh Wu, Xiaoxin Li
Publikováno v:
Graefes Archive for Clinical and Experimental Ophthalmology
Graefe's Archive for Clinical and Experimental Ophthalmology
Graefe's Archive for Clinical and Experimental Ophthalmology, Springer Verlag, 2021, 259 (3), pp.567-574. ⟨10.1007/s00417-021-05097-0⟩
Graefe's Archive for Clinical and Experimental Ophthalmology
Graefe's Archive for Clinical and Experimental Ophthalmology, Springer Verlag, 2021, 259 (3), pp.567-574. ⟨10.1007/s00417-021-05097-0⟩
Purpose Following the first wave of the COVID-19 pandemic in early 2020, the easing of strict measures to reduce its spread has led to a resurgence of cases in many countries at both the national and local level. This article addresses how guidance f
Autor:
Patricia A. D'Amore, Marcus Fruttiger, Sandro De Falco, George N. Lambrou, Antonia M. Joussen, Florian Sennlaub, Kay D. Rittenhouse, Akiyoshi Uemura, Thomas Langmann, K. T. M. Johnson, Lynne R. Brunck
Publikováno v:
Progress in retinal and eye research
Progress in Retinal and Eye Research
Progress in Retinal and Eye Research, Elsevier, 2021, pp.100954. ⟨10.1016/j.preteyeres.2021.100954⟩
Progress in retinal and eye research (Online) 84 (2021). doi:10.1016/j.preteyeres.2021.100954
info:cnr-pdr/source/autori:Uemura A.; Fruttiger M.; D'Amore P.A.; De Falco S.; Joussen A.M.; Sennlaub F.; Brunck L.R.; Johnson K.T.; Lambrou G.N.; Rittenhouse K.D.; Langmann T./titolo:VEGFR1 signaling in retinal angiogenesis and microinflammation/doi:10.1016%2Fj.preteyeres.2021.100954/rivista:Progress in retinal and eye research (Online)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:84
Progress in Retinal and Eye Research
Progress in Retinal and Eye Research, Elsevier, 2021, pp.100954. ⟨10.1016/j.preteyeres.2021.100954⟩
Progress in retinal and eye research (Online) 84 (2021). doi:10.1016/j.preteyeres.2021.100954
info:cnr-pdr/source/autori:Uemura A.; Fruttiger M.; D'Amore P.A.; De Falco S.; Joussen A.M.; Sennlaub F.; Brunck L.R.; Johnson K.T.; Lambrou G.N.; Rittenhouse K.D.; Langmann T./titolo:VEGFR1 signaling in retinal angiogenesis and microinflammation/doi:10.1016%2Fj.preteyeres.2021.100954/rivista:Progress in retinal and eye research (Online)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:84
International audience; Five vascular endothelial growth factor receptor (VEGFR) ligands (VEGF-A, -B, -C, -D, and placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds to VEGF receptors 1 and 2 (VEGFR1/2), whereas VEGF-B and PlGF o
Autor:
Monica Lövestam-Adrian, Rafael Navarro, Paolo Lanzetta, Annabelle A. Okada, Ian Pearce, Adrian Koh, George N. Lambrou, Francisco Rodríguez, Xiaoxin Li, Lihteh Wu, Bora Eldem, Antonia M. Joussen, Jean-François Korobelnik, Anat Loewenstein, David T. Wong
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Graefes Archive for Clinical and Experimental Ophthalmology
Universidad del Rosario
instacron:Universidad del Rosario
Graefes Archive for Clinical and Experimental Ophthalmology
Purpose There is an urgent need to address how to best provide ophthalmic care for patients with retinal disease receiving intravitreal injections with anti-vascular endothelial growth factor agents during the ongoing global COVID-19 pandemic. This a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e97e37499af6914d901aacf71305f1b
http://hdl.handle.net/20.500.12278/26073
http://hdl.handle.net/20.500.12278/26073
Publikováno v:
Retina (Philadelphia, Pa.)
This publication summarizes the recommendations of the Vision Academy Steering Committee for the management of neovascular age-related macular degeneration in patients with poor response to anti–vascular endothelial growth factor therapy, consideri
Autor:
George N. Lambrou, Sascha Fauser
Publikováno v:
Survey of Ophthalmology. 60:138-152
Anti-vascular endothelial growth factor (anti-VEGF) therapies for neovascular age-related macular degeneration (nAMD) have proven efficacy at a study-population level, although individual patient responses vary, with most of the patients responding w
Autor:
Dennis Brooks, Maria E. Kallberg, Gustavo A. García-Sánchez, Nancy J. Szabo, Kirk N. Gelatt, George N. Lambrou
Publikováno v:
Veterinary Ophthalmology. 10:46-52
Purpose To document differences in the levels of the endothelin-1 peptide, nitric oxide, and glutamate in aqueous humor and vitreous in the dog eye with spontaneous glaucoma compared to the normal dog eye. Methods Samples of aqueous humor and vitreou
Autor:
Maria K. Storch, Robert Weissert, Balázs Balatoni, Peter Hiestand, Eva-M. Swoboda, Carolyn A. Foster, Agnieszka Koziel, Vinzenz Schönborn, George N. Lambrou
Publikováno v:
Brain Research Bulletin. 74:307-316
FTY720 (fingolimod) is an oral sphingosine 1-phosphate (S1P) receptor modulator under development for the treatment of multiple sclerosis (MS). To elucidate its effects in the central nervous system (CNS), we compared functional parameters of nerve c